SUN PHARMACEUTICAL INDUS (NSE: SUNPHARMA) Q3 2026 Earnings Call dated Jan. 31, 2026 Corporate Participants: Abhishek Sharma — Vice President, Head of Investor Relations & Strategic Projects Jayashree Satagopan — Chief Financial Officer Kirti Ganorkar — Managing Director Richard Ascroft — CEO, North America Aalok Shanghvi — Chief Operating Officer Dilip Shanghvi — Chairman Analysts: […]
SUN PHARMACEUTICAL INDUS (NSE: SUNPHARMA) Q2 2025 Earnings Call dated Oct. 28, 2024 Corporate Participants: Abhishek Sharma — Vice President & Head, Investor Relations and Strategic Projects C.S. Muralidharan — Chief Financial Officer Kirti Ganorkar — Chief Executive Officer, India Business Abhay Gandhi — Chief Executive Officer, North America Dilip Shanghvi — Chairman and Managing […]
SUN PHARMACEUTICAL INDUS (NSE: SUNPHARMA) Q3 2025 Earnings Call dated Jan. 31, 2025 Corporate Participants: Abhishek Sharma — Vice President and Head of Investor Relations and Strategic Projects C.S. Muralidharan — Chief Financial Officer Kirti Ganorkar — Chief Executive Officer, India Business Abhay Gandhi — Chief Executive Officer, North America Business Dilip Shanghvi — Chairman […]
SUN PHARMACEUTICAL INDUS (NSE: SUNPHARMA) Q4 2025 Earnings Call dated May. 22, 2025 Corporate Participants: Abhishek Sharma — Vice President and Head of Investor Relations and Strategic Projects C. S. Muralidharan — Chief Financial Officer Kirti Ganorkar — Chief Executive Officer, India Business Abhay Gandhi — Chief Executive Officer, North America Dilip Shanghvi — Chairman […]
Sun Pharmaceutical Industries (NSE: SUNPHARMA) Q1 2026 Earnings Call dated Jul. 31, 2025 Corporate Participants: Unidentified Speaker Abhishek Sharma — Vice President and Head of Investor Relations and Strategic Projects Jayashree Satagopan — Chief Financial Officer Kirti Ganorkar — Chief Executive Officer Richard Ascroft — Sun Pharmaceutical Industries Dilip Shanghvi — Chairman and Managing Director […]
Sun Pharmaceutical Industries Ltd., the fourth largest specialty generic pharmaceutical company in the world, in its Q3 earnings call discussed about strong Q3 performance with significant specialty business growth, though the company expects lower specialty sales next quarter due to inventory buildup at partner locations. The company’s India business grew 14%, driven by volume/new products […]
SUN PHARMACEUTICAL INDUSTRIES LIMITED (NSE : SUNPHARMA) Q4 FY23 Earnings Concall dated May. 26, 2023. Corporate Participants: Abhishek Sharma — Head of Investor Relations Dilip Shanghvi — Managing Director C. S. Muralidharan — Chief Financial Officer Kirti Ganorkar — Chief Executive Officer, India Business Abhay Gandhi — Chief Executive Officer, North America Analysts: Chirag Dagli […]
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) Q3 FY23 Earnings Concall dated Jan. 31, 2023 Corporate Participants: Abhishek Sharma — Head of Investor Relations and Strategic Projects Dilip Shanghvi — Managing Director C. S. Muralidharan — Group Chief Financial Officer Kirti Ganorkar — Chief Executive Officer-India Business Abhay Gandhi — Chief Executive Officer-North America Business Analysts: Naushad Chaudhary — Aditya Birla Sun Life AMC — Analyst Tushar Manudhane — Motilal […]
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Q2 FY23 Earnings Concall dated Nov. 01, 2022 Corporate Participants: Nimish Desai — Investor Relations Dilip S. Shanghvi — Managing Director C. S. Muralidharan — Chief Financial Officer Kirti Ganorkar — Head (India Business) Abhay Gandhi — Chief Executive Officer (North America Business) Analysts: Tushar Manudhane — Motilal Oswal Financial […]
Sun Pharmaceutical Industries Ltd (NSE:SUNPHARMA) Q1 FY23 Earnings Concall dated Jul. 29, 2022 Corporate Participants: Nimish Desai — Investor Relations Dilip Shanghvi — Managing Director C. S. Muralidharan — Chief Financial Officer Kirti Ganorkar — Chief Executive Officer, India Business Abhay Gandhi — Chief Executive Officer, North America Analysts: Kunal Dhamesha — Macquarie Capital — […]